Australia's Genetic Signatures jumps on strong sales outlook

Genetic Signatures

21/12/2021 03:52

** Shares of Genetic Signatures Ltd  GSS.AX  rise as much as
3.1% to A$1.330, hitting highest since Dec 8 
    ** Molecular diagnostics co expects H1 sales of at least
A$21 mln ($14.93 mln) vs A$18.7 mln reported last year
 urn:newsml:reuters.com:*:nASX5hJgXq
    ** Adds that Omicron variant of COVID-19 has pushed up
testing volumes; expects this trend to continue in FY22
    ** Stock has fallen 35.8% this year, as of last close


($1 = 1.4063 Australian dollars)

 (Reporting by Jaskiran Singh in Bengaluru)
 ((Jaskiran.Singh@thomsonreuters.com;))